APA

Varrin-Doyer M., Pekarek K. L., Spencer C. M., Bernard C. C. A., Sobel R. A., Cree B. A. C., Schulze-Topphoff U. & Zamvil S. S. (2016). Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression. : Neurology(R) neuroimmunology & neuroinflammation.

Chicago

Varrin-Doyer Michel, Pekarek Kara L, Spencer Collin M, Bernard Claude C A, Sobel Raymond A, Cree Bruce A C, Schulze-Topphoff Ulf and Zamvil Scott S. 2016. Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression. : Neurology(R) neuroimmunology & neuroinflammation.

Harvard

Varrin-Doyer M., Pekarek K. L., Spencer C. M., Bernard C. C. A., Sobel R. A., Cree B. A. C., Schulze-Topphoff U. and Zamvil S. S. (2016). Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression. : Neurology(R) neuroimmunology & neuroinflammation.

MLA

Varrin-Doyer Michel, Pekarek Kara L, Spencer Collin M, Bernard Claude C A, Sobel Raymond A, Cree Bruce A C, Schulze-Topphoff Ulf and Zamvil Scott S. Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression. : Neurology(R) neuroimmunology & neuroinflammation. 2016.